Second malaria vaccine launched in Ivory Coast in new milestone By Maggie Fick LONDON, July 15 (Reuters) - The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine programme using shots developed by the University of Oxford and the Serum Institute of India. The introduction of the World Health Organization (WHO)-approved R21 vaccine comes six months after the first malaria vaccine, called RTS,S and developed by British drugmaker GSK GSK.L , began b

BRIEF-German Cartel Office: GSK Cleared To Buy Curevac Assets July 12 (Reuters) - CureVac NV 5CV.DE : GERMAN CARTEL OFFICE: GSK CLEARED TO BUY CUREVAC ASSETS Source text Further company coverage: 5CV.DE

BRIEF-GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season July 11 (Reuters) - GSK plc GSK.L : GSK BEGINS SHIPPING INFLUENZA VACCINE DOSES FOR 2024-25 SEASON GSK: EXPECTS TO DISTRIBUTE OVER 36 MILLION DOSES OF ITS TRIVALENT INFLUENZA VACCINES IN US THIS SEASON Source text for Eikon: ID:nBw7xSr4xa Further company coverage: GSK.L

EUROPE RESEARCH ROUNDUP-Diageo, Publicis, Wolters Kluwer NV July 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Diageo, Publicis and Wolters Kluwer NV, on Thursday. HIGHLIGHTS * Diageo DGE.L : HSBC cuts target price to 3,300p from 3,500p * Mfe-Mediaforeurope NV MFEB.MI : JP Morgan raises to overweight from neutral * Prosiebensat 1 Media SE PSMGn.DE : JP Morgan raises to overweight from neutral * Publicis PUBP.PA : JP Morgan cuts

Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births By Christy Santhosh July 8 (Reuters) - Pfizer's PFE.N respiratory syncytial virus (RSV) vaccine for pregnant women was not tied to a higher risk of pre-term or early births, according to a study published on Monday that analyzed real-world use of the shots. The vaccine Abrysvo was approved by the U.S.